Medicine
Teriflunomide 14 mg tablet
Teriflunomide 14 mg tablet is a generic prescription medicine for oral use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Teriflunomide
- Brand
- Sold under the generic name
- Strength
- 14 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 2 blister pack, 30 tablets, 1000 tablets and 27 more
- Manufacturers
- Alembic PharmaceuticalsIndiaZydus LifesciencesIndiaGlenmark PharmaceuticalsIndiaMSN LaboratoriesIndiaNatco PharmaIndiaAurobindo PharmaIndiaBioconIndiaAccord HealthcareIndiaCamber PharmaceuticalsIndiaConcord BiotechIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AK02 Teriflunomide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 April 2019
- Identifiers
- RxCUI 1310525, 1310533DailyMed set ID c424959d-00c9-4e76-aba6-cc7464d8e903, 2b084b44-f15b-4b16-b700-4382434f2136, 2fd80242-c607-4c50-b497-8259abb4a2f8 +13NDC 0480-3156, 46708-314, 59651-055 +14Application ANDA209700, ANDA209572, ANDA209638 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 46708-314-14 | Alembic PharmaceuticalsIndia | 25 January 2023 |
| 30 tablet, film coated in 1 bottle | 46708-314-30 | Alembic PharmaceuticalsIndia | 25 January 2023 |
| 1000 tablet, film coated in 1 bottle | 46708-314-91 | Alembic PharmaceuticalsIndia | 25 January 2023 |
| 2 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 62332-314-14 | Alembic PharmaceuticalsIndia | 25 January 2023 |
| 30 tablet, film coated in 1 bottle | 62332-314-30 | Alembic PharmaceuticalsIndia | 25 January 2023 |
| 1000 tablet, film coated in 1 bottle | 62332-314-91 | Alembic PharmaceuticalsIndia | 25 January 2023 |
| 2 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 69539-033-41 | MSN LaboratoriesIndia | 24 April 2019 |
| 30 tablet, film coated in 1 bottle | 69539-316-30 | MSN LaboratoriesIndia | 4 February 2023 |
| 2 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 69539-316-41 | MSN LaboratoriesIndia | 24 April 2019 |
| 30 tablet, film coated in 1 bottle | 70710-1115-3 | Zydus LifesciencesIndia | 14 February 2023 |
| 2 carton in 1 carton / 1 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 70710-1115-8 | Zydus LifesciencesIndia | 14 February 2023 |
| 30 tablet, film coated in 1 bottle | 70771-1011-3 | Zydus LifesciencesIndia | 14 February 2023 |
| 2 carton in 1 carton / 1 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 70771-1011-8 | Zydus LifesciencesIndia | 14 February 2023 |
| 30 tablet, film coated in 1 bottle | 16729-400-10 | Accord HealthcareIndia | 13 March 2023 |
| 2 blister pack in 1 carton / 14 tablet in 1 blister pack | 59651-055-28 | Aurobindo PharmaIndia | 28 February 2023 |
| 30 tablet in 1 bottle | 59651-055-30 | Aurobindo PharmaIndia | 28 February 2023 |
| 30 tablet, film coated in 1 bottle | 70377-018-11 | BioconIndia | 13 March 2023 |
| 2 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 70377-018-91 | BioconIndia | 13 March 2023 |
| 30 tablet, film coated in 1 bottle | 31722-247-30 | Camber PharmaceuticalsIndia | 13 March 2023 |
| 30 tablet, film coated in 1 bottle | 68254-5010-1 | Concord BiotechIndia | 7 July 2025 |
| 2 blister pack in 1 carton / 14 tablet, film coated in 1 blister pack | 68462-424-15 | Glenmark PharmaceuticalsIndia | 19 January 2023 |
| 30 tablet, film coated in 1 bottle | 68462-424-30 | Glenmark PharmaceuticalsIndia | 19 January 2023 |
| 1 blister pack in 1 carton / 5 tablet, film coated in 1 blister pack | 68462-424-85 | Glenmark PharmaceuticalsIndia | 19 January 2023 |
| 30 tablet in 1 bottle | 69339-170-03 | Natco PharmaIndia | 2 January 2024 |
| 90 tablet in 1 bottle | 69339-170-09 | Natco PharmaIndia | 2 January 2024 |
| 2 blister pack in 1 carton / 30 tablet in 1 blister pack | 69339-170-93 | Natco PharmaIndia | 17 June 2023 |
| 30 tablet, film coated in 1 bottle | 82249-112-30 | Civica Script | 26 October 2026 |
| 30 tablet, film coated in 1 bottle, plastic | 0378-0628-93 | Mylan Pharmaceuticals | 31 March 2023 |
| 30 tablet, film coated in 1 bottle | 0480-3156-56 | Teva Pharmaceuticals | 13 March 2023 |
| 30 tablet, film coated in 1 bottle | 42291-831-30 | AvKARE | 20 April 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Teriflunomide 14 mg tablet.
Other strengths and forms of Teriflunomide
Clinical summary
Teriflunomide is a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. MedsAcross supplies Teriflunomide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TeriflunomideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Aubagio prescribing information (Genzyme) · U.S. National Library of Medicine, DailyMed
- Aubagio: European public assessment report (EPAR) · European Medicines Agency
- Teriflunomide Accord: European public assessment report (EPAR) · European Medicines Agency
Need Teriflunomide 14 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.